Delayed increase of plasma selenoproteins and absence of side effect induced by infusion of pharmacological dose of sodium selenite in septic shock: Secondary analysis of a multicenter, randomized controlled trial.


Journal

Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements (GMS)
ISSN: 1878-3252
Titre abrégé: J Trace Elem Med Biol
Pays: Germany
ID NLM: 9508274

Informations de publication

Date de publication:
Sep 2022
Historique:
received: 30 01 2022
revised: 14 06 2022
accepted: 24 06 2022
pubmed: 7 7 2022
medline: 9 8 2022
entrez: 6 7 2022
Statut: ppublish

Résumé

In sepsis, neutrophil respiratory bursts participate in endothelium damage, the first step to multiple organ failure. In plasma two antioxidant selenoenzymes, which protect the endothelium, decrease: selenoprotein-P, and to a lesser extent glutathione peroxidase (GPX3). Sodium selenite (Na At baseline, plasma Se was about a quarter of reference values. From baseline to day-4 plasma Se, selenoprotein-P and GPX3 significantly increased by 3.9, 2.7 and 1.8 respectively in the Na Continuous infusion of Na

Sections du résumé

BACKGROUND BACKGROUND
In sepsis, neutrophil respiratory bursts participate in endothelium damage, the first step to multiple organ failure. In plasma two antioxidant selenoenzymes, which protect the endothelium, decrease: selenoprotein-P, and to a lesser extent glutathione peroxidase (GPX3). Sodium selenite (Na
MAIN RESULTS RESULTS
At baseline, plasma Se was about a quarter of reference values. From baseline to day-4 plasma Se, selenoprotein-P and GPX3 significantly increased by 3.9, 2.7 and 1.8 respectively in the Na
CONCLUSION CONCLUSIONS
Continuous infusion of Na

Identifiants

pubmed: 35793609
pii: S0946-672X(22)00111-0
doi: 10.1016/j.jtemb.2022.127031
pii:
doi:

Substances chimiques

Lactates 0
Selenoprotein P 0
Selenoproteins 0
Glutathione Peroxidase EC 1.11.1.9
Selenium H6241UJ22B
Sodium Selenite HIW548RQ3W

Types de publication

Journal Article Multicenter Study Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Pagination

127031

Informations de copyright

Copyright © 2022 Elsevier GmbH. All rights reserved.

Auteurs

Xavier Forceville (X)

Service de Réanimation Médico-Chirurgicale-USC, Grand Hôpital de l'Est Francilien, site de Meaux, Hôpital Saint Faron, 6-8 rue Saint Fiacre, 77104 Meaux, France; Univ Rennes, CHU Rennes, Inserm, CIC 1414 (Centre d'Investigation Clinique de Rennes), F-35000 Rennes, France. Electronic address: xforceville@invivo.edu.

Bruno Laviolle (B)

Univ Rennes, CHU Rennes, Inserm, CIC 1414 (Centre d'Investigation Clinique de Rennes), F-35000 Rennes, France. Electronic address: bruno.laviolle@chu-rennes.fr.

Jolanta Gromadzinska (J)

Biological and Environmental Monitoring Department, Nofer Institute of Occupational Medicine, 8 Teresy St., 90-950 Lodz, Poland. Electronic address: Jola@imp.lodz.pl.

Anne Boutten (A)

Laboratoire de biochimie, Hôpital Bichat-Claude Bernard, APHP, 46 rue Henri Huchard, 75877 Paris cedex 18, France. Electronic address: anne.boutten@aphp.fr.

Pierre Van Antwerpen (P)

Pharmacognosy, Bioanalysis and Drug Discovery and Analytical Platform of the Faculty of Pharmacy, Université libre de Bruxelles (ULB), Bld du Triomphe Campus Plaine 205/05, 1050 Bruxelles, Belgium. Electronic address: pierre.van.antwerpen@ulb.be.

Elisabeth Plouvier (E)

Laboratoire de Biochimie, Grand Hôpital de l'Est Francilien, site de Meaux, Hôpital Saint Faron, 6-8 rue Saint Fiacre, 77104 Meaux, France. Electronic address: eplouvier@ghef.fr.

Djillali Annane (D)

Service de Réanimation Médicale, Hôpital Raymond Poincaré, 104 boulevard Raymond Poincaré, 92380 Garches, France; U1173 Lab. of Inflammation & Infection, (Fédération Hospitalo-Universitaire) FHU SEPSIS, Université Paris Saclay-campus (Université de Versailles Saint-Quentin-en-Yvelines) UVSQ, France. Electronic address: djillali.annane@rpc.aphp.fr.

Eric Bellissant (E)

Univ Rennes, CHU Rennes, Inserm, CIC 1414 (Centre d'Investigation Clinique de Rennes), F-35000 Rennes, France. Electronic address: eric.bellissant@univ-rennes1.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH